BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 19382089)

  • 21. [Cystatin C, beta2-microglobulin and C-reactive protein in hemodiafiltration and on-line endogenous liquid reinfusion and in low flux polysulphone bicarbonate conventional hemodialysis].
    Cristofano C; Vernaglione L; Perniola MA; Lo Barco C; Muscogiuri P; Chimienti S
    G Ital Nefrol; 2004; 21 Suppl 30():S197-200. PubMed ID: 15750984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodialysis timing, survival, and cardiovascular outcomes in the Hemodialysis (HEMO) Study.
    Ng YH; Meyer KB; Kusek JW; Yan G; Rocco MV; Kimmel PL; Benz RL; Beddhu S; Dwyer JT; Toto RD; Eknoyan G; Unruh ML
    Am J Kidney Dis; 2006 Apr; 47(4):614-24. PubMed ID: 16564939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Is conventional hemodialysis an appropriate dialysis?].
    Andrés E
    Nefrologia; 2005; 25 Suppl 2():10-4. PubMed ID: 16050395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular access for hemodialysis: the impact on morbidity and mortality.
    Di Iorio BR; Bellizzi V; Cillo N; Cirillo M; Avella F; Andreucci VE; De Santo NG
    J Nephrol; 2004; 17(1):19-25. PubMed ID: 15151255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prevalence of pre-obesity and obesity in uremic hemodialysis patients from Puglia and Lucania].
    Querques M; Strippoli GF; Dell'Aquila R; Gallucci M; Di Iorio B; Manno C;
    G Ital Nefrol; 2002; 19(4):432-8. PubMed ID: 12369046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Convective dialysis therapies, current status and perspective.
    Ledebo I
    Ther Apher Dial; 2005 Jun; 9(3):223-7. PubMed ID: 15966994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysis.
    Krane V; Krieter DH; Olschewski M; März W; Mann JF; Ritz E; Wanner C
    Am J Kidney Dis; 2007 Feb; 49(2):267-75. PubMed ID: 17261429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quotidian hemodialysis and inflammation associated with chronic kidney disease.
    Hamlett L; Haragsim L
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):e35-42. PubMed ID: 17603973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
    Pellicano R; Polkinghorne KR; Kerr PG
    Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term outcome in hemodialysis: morbidity and mortality.
    Pozzoni P; Del Vecchio L; Pontoriero G; Di Filippo S; Locatelli F
    J Nephrol; 2004; 17 Suppl 8():S87-95. PubMed ID: 15599892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A critical assessment of uremia research.
    Locatelli F; Di Filippo S; Pozzoni P
    Blood Purif; 2006; 24(1):71-6. PubMed ID: 16361845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of initial blood pressure on the mortality of diabetics undergoing renal replacement therapy.
    Abderrahim E; Zouaghi K; Kheder A; Cherif M; Boubaker K; Mahfoudhi M; Hedri H; Ounissi M; Ben Hamida F; Ben Moussa F; Ben Abdallah T; El Younsi F; Kâaroud H; Béji S; Goucha R; Ben Maïz H
    Transplant Proc; 2004; 36(6):1820-3. PubMed ID: 15350486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Factors which influence phosphorus removal in hemodialysis].
    Gallar P; Ortiz M; Ortega O; Rodríguez I; Seijas V; Carreño A; Oliet A; Vigil A
    Nefrologia; 2007; 27(1):46-52. PubMed ID: 17402879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pilot study to assess increased dialysis efficiency in patients with limited blood flow rates due to vascular access problems.
    Mandolfo S; Borlandelli S; Imbasciati E; Badalamenti S; Graziani G; Sereni L; Varesani M; Wratten ML; Corsi A; Elli A
    Hemodial Int; 2008 Jan; 12(1):55-61. PubMed ID: 18271842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nutritional status in hemodialysis patients: options for on-line convective treatment.
    Savica V; Ciolino F; Monardo P; Mallamace A; Savica R; Santoro D; Bellinghieri G
    J Ren Nutr; 2006 Jul; 16(3):237-40. PubMed ID: 16825027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors and underlying cardiovascular diseases in incident ESRD patients.
    Di Benedetto A; Marcelli D; D'Andrea A; Cice G; D'Isa S; Cappabianca F; Pacchiano G; D'Amato R; Oggero AR; Bonanno D; Pergamo O; Calabrò R
    J Nephrol; 2005; 18(5):592-8. PubMed ID: 16299687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reuse-associated mortality in incident hemodialysis patients in the United States, 2000 to 2001.
    Fan Q; Liu J; Ebben JP; Collins AJ
    Am J Kidney Dis; 2005 Oct; 46(4):661-8. PubMed ID: 16183421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diabetes in hemodialysis: study of differential factors].
    Sanz París A; Lou Arnal LM; Gutiérrez Colón JA; Alvarez Lipe A; Albero Gamboa R
    An Med Interna; 1998 Apr; 15(4):183-8. PubMed ID: 9608060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Revisiting the Middle Molecule Hypothesis of Uremic Toxicity: A Systematic Review of Beta 2 Microglobulin Population Kinetics and Large Scale Modeling of Hemodialysis Trials In Silico.
    Roumelioti ME; Nolin T; Unruh ML; Argyropoulos C
    PLoS One; 2016; 11(4):e0153157. PubMed ID: 27055286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The importance of convective transport.
    Locatelli F; Manzoni C; Di Filippo S
    Kidney Int Suppl; 2002 May; (80):115-20. PubMed ID: 11982825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.